VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announces the release of Volition's new lung cancer primer, "Lung Cancer: Hope of a Brighter Tomorrow." The report ...
Upgraded PRISM, SPG9000, and ARGUS systems to meet new SMPTE and UHD requirements NEVADA CITY, CA / ACCESS Newswire / March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback